These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32602952)

  • 1. Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications.
    Jiang J; Miao Y; Zhao Y; Lu X; Zhou P; Zhou X; Chen Z; Du D
    Clin Transplant; 2020 Sep; 34(9):e14025. PubMed ID: 32602952
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy.
    Naeem S; Gohh R; Bayliss G; Cosgrove C; Farmakiotis D; Merhi B; Morrissey P; Osband A; Bailey JA; Sweeney J; Rogers R
    Transpl Infect Dis; 2021 Feb; 23(1):e13451. PubMed ID: 32815238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.
    Bayrak M; Çadirci K
    Pan Afr Med J; 2021; 38():273. PubMed ID: 34122700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Convalescent Plasma Therapy in Kidney Transplant Recipients With Severe COVID-19: A Single-Center Prospective Cohort Study.
    Gupta A; Kute VB; Patel HV; Engineer DP; Banerjee S; Modi PR; Rizvi SJ; Mishra VV; Patel AH; Navadiya V
    Exp Clin Transplant; 2021 Apr; 19(4):304-309. PubMed ID: 33605203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease.
    Das SS; Chaudhuri K; Biswas RN
    Indian Pediatr; 2021 Jan; 58(1):89-90. PubMed ID: 33257603
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Convalescent Plasma to Treat Mild to Moderate COVID-19 in Kidney Transplant Patients: A Propensity Score Matching Analysis.
    Cristelli MP; Langhi Junior DM; Viana LA; de Andrade LGM; Martins SBS; Dreige YC; Bordim JO; Tedesco-Silva H; Medina-Pestana J
    Transplantation; 2022 Jan; 106(1):e92-e94. PubMed ID: 34581314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis.
    Zhang LL; Liu Y; Guo YG; Chang J; Gao B; Li ZZ; Geng W; Hu P; Song B; Zhang X; Wan CC
    Turk J Haematol; 2021 Feb; 18(1):74-76. PubMed ID: 32988811
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City.
    Rahman F; Liu STH; Taimur S; Jacobs S; Sullivan T; Dunn D; Baneman E; Fuller R; Aberg JA; Bouvier N; Rana MM
    Clin Transplant; 2020 Dec; 34(12):e14089. PubMed ID: 32918761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Second Wave of COVID-19 Disease in a Kidney Transplant Recipient Cohort: A Single-center Experience in Belgium.
    Georgery H; Devresse A; Scohy A; Kabamba B; Darius T; Buemi A; De Greef J; Belkhir L; Yombi JC; Goffin E; Kanaan N
    Transplantation; 2021 Mar; 105(3):e41-e42. PubMed ID: 33617210
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
    Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
    Basic-Jukic N
    Med Hypotheses; 2020 Nov; 144():109903. PubMed ID: 32563969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma.
    Niu A; McDougal A; Ning B; Safa F; Luk A; Mushatt DM; Nachabe A; Zwezdaryk KJ; Robinson J; Peterson T; Socola F; Safah H; Hu T; Saba NS
    Bone Marrow Transplant; 2020 Dec; 55(12):2354-2356. PubMed ID: 32541689
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
    Fabricius MM; Dandachi D
    Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma.
    Wright Z; Bersabe A; Eden R; Bradley J; Cap A
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):66-68. PubMed ID: 32682684
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma.
    Lindemann M; Krawczyk A; Dolff S; Konik M; Rohn H; Platte M; Thümmler L; Schwarzkopf S; Schipper L; Bormann M; van de Sand L; Breyer M; Klump H; Knop D; Lenz V; Temme C; Dittmer U; Horn PA; Witzke O
    J Med Virol; 2021 May; 93(5):3047-3054. PubMed ID: 33527424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.
    Figlerowicz M; Mania A; Lubarski K; Lewandowska Z; Służewski W; Derwich K; Wachowiak J; Mazur-Melewska K
    Transfus Apher Sci; 2020 Oct; 59(5):102866. PubMed ID: 32636116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: A case report.
    Ragab D; Salah-Eldin H; Afify M; Soliman W; Badr MH
    J Med Virol; 2021 Apr; 93(4):1854-1856. PubMed ID: 33107628
    [No Abstract]   [Full Text] [Related]  

  • 18. Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.
    Sahu KK; Jindal V; Siddiqui AD; Cerny J; Gerber JM
    J Med Virol; 2020 Nov; 92(11):2251-2253. PubMed ID: 32437024
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of convalescent plasma in COVID-19 patients with immunosuppression.
    Senefeld JW; Klassen SA; Ford SK; Senese KA; Wiggins CC; Bostrom BC; Thompson MA; Baker SE; Nicholson WT; Johnson PW; Carter RE; Henderson JP; Hartman WR; Pirofski LA; Wright RS; Fairweather L; Bruno KA; Paneth NS; Casadevall A; Joyner MJ
    Transfusion; 2021 Aug; 61(8):2503-2511. PubMed ID: 34036587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial.
    Madariaga MLL; Guthmiller JJ; Schrantz S; Jansen MO; Christensen C; Kumar M; Prochaska M; Wool G; Durkin-Celauro A; Oh WH; Trockman L; Vigneswaran J; Keskey R; Shaw DG; Dugan H; Zheng NY; Cobb M; Utset H; Wang J; Stovicek O; Bethel C; Matushek S; Giurcanu M; Beavis KG; di Sabato D; Meltzer D; Ferguson MK; Kress JP; Shanmugarajah K; Matthews JB; Fung JF; Wilson PC; Alverdy JC; Donington JS
    J Intern Med; 2021 Apr; 289(4):559-573. PubMed ID: 33034095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.